Skip to main content

Spinal muscular atrophy

Dr Gina O’Grady provides an update on spinal muscular atrophy (SMA), including how prompt recognition of hypotonia and timely referral means disease modifying therapies can be started early, which may alter prognosis and longevity.


  1. Play now
  2. Play now
  3. Play now
  4. Play now
  5. Play now
  6. Play now
  7. Play now
  8. Play now
  9. Play now
  10. Play now
  11. Play now
  12. Play now
  13. Play now
  14. Play now
  15. Play now
  16. Play now
  17. Play now
  18. Play now
  19. Play now
  20. Play now
  21. Play now

Take home messages


  1. Hypotonia in neonates
  2. Nusinersen
  3. International Standards of Care for SMA
  4. Spinal Muscular Atrophy

Patient Resources

  1. Spinal Muscular Atrophy
  2. Spinal Muscular Atrophy


Gina O'Grady

Paediatric Neurologist

Gina O’Grady is a Paediatric Neurologist at Starship Children’s Hospital.  She has a subspeciality interest in paediatric neuromuscular disease and genetic diagnosis.  She runs a neuromuscular management clinic at Starship Children’s Hospital and has lead the roll out of disease modifying therapy for the treatment of Spinal Muscular Atrophy (SMA) in New Zealand.

Recognition of Learning Activities RNZCGP Logo

Don't forget to log your time with The Royal New Zealand College of General Practitioners portal for recognition of learning activities.

Log your CPD

The Goodfellow Unit podcast is funded in part by the Royal New Zealand College of General Practitioners.